Oncotarget

Research Papers:

Increased cFLIP expression in thymic epithelial tumors blocks autophagy via NF-κB signalling

Djeda Belharazem _, Albert Grass, Cornelia Paul, Mario Vitacolonna, Berthold Schalke, Ralf J. Rieker, Daniel Körner, Philipp Jungebluth, Katja Simon-Keller, Peter Hohenberger, Eric M. Roessner, Karsten Wiebe, Thomas Gräter, Thomas Kyriss, German Ott, Peter Geserick, Martin Leverkus, Philipp Ströbel and Alexander Marx

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:89580-89594. https://doi.org/10.18632/oncotarget.15929

Metrics: PDF 794 views  |   HTML 1259 views  |   ?  


Abstract

Djeda Belharazem1, Albert Grass1, Cornelia Paul1, Mario Vitacolonna2, Berthold Schalke3, Ralf J. Rieker4,5, Daniel Körner6, Philipp Jungebluth6, Katja Simon-Keller1, Peter Hohenberger2, Eric M. Roessner2, Karsten Wiebe7, Thomas Gräter8, Thomas Kyriss9, German Ott10,11, Peter Geserick12, Martin Leverkus12,13,*, Philipp Ströbel14 and Alexander Marx1

1Institute of Pathology and Medical Research Center (ZMF), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany

2Department of Thoracic Surgery, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany

3Department of Neurology, University of Regensburg, Regensburg, Germany

4Institute of Pathology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany

5Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany

6Department of Thoracic Surgery, Thorax Clinic, University of Heidelberg, Heidelberg, Germany

7Department of Thoracic Surgery, University of Münster, Münster, Germany

8Department of Thoracic Surgery, Clinic Löwenstein, Löwenstein, Germany

9Department of Thoracic Surgery, Clinic Schillerhöhe, Robert-Bosch-Hospital, Gerlingen, Germany

10Department of Clinical Pathology, Robert-Bosch-Hospital, Stuttgart, Germany

11Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology, Stuttgart, Germany

12Department of Dermatology, Venereology, and Allergology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

13Department for Dermatology and Allergology, University Hospital Aachen, RWTH Aachen, Aachen, Germany

14Institute of Pathology, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany

*Deceased

Correspondence to:

Djeda Belharazem, email: djeda.belharazem@medma.uni-heidelberg.de

Keywords: thymic tumors, cFLIP, NF-κB, senescence, autophagy

Received: September 01, 2016 Accepted: December 26, 2016 Published: February 06, 2017

ABSTRACT

The anti-apoptotic cellular FLICE-like inhibitory protein cFLIP plays a pivotal role in normal tissues homoeostasis and the development of many tumors, but its role in normal thymus (NT), thymomas and thymic carcinomas (TC) is largely unknown.

Expression, regulation and function of cFLIP were analyzed in biopsies of NT, thymomas, thymic squamous cell carcinomas (TSCC), thymic epithelial cells (TECs) derived thereof and in the TC line 1889c by qRT-PCR, western blot, shRNA techniques, and functional assays addressing survival, senescence and autophagy. More than 90% of thymomas and TSCCs showed increased cFLIP expression compared to NT. cFLIP expression declined with age in NTs but not in thymomas. During short term culture cFLIP expression levels declined significantly slower in neoplastic than non-neoplastic primary TECs. Down-regulation of cFLIP by shRNA or NF-κB inhibition accelerated senescence and induced autophagy and cell death in neoplastic TECs.

The results suggest a role of cFLIP in the involution of normal thymus and the development of thymomas and TSCC. Since increased expression of cFLIP is a known tumor escape mechanism, it may serve as tissue-based biomarker in future clinical trials, including immune checkpoint inhibitor trials in the commonly PD-L1high thymomas and TCs.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 15929